Intech Investment Management LLC Trims Position in Acadia Healthcare Company, Inc. $ACHC

Intech Investment Management LLC lowered its position in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 57.6% during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 35,313 shares of the company’s stock after selling 47,972 shares during the quarter. Intech Investment Management LLC’s holdings in Acadia Healthcare were worth $874,000 at the end of the most recent quarter.

A number of other hedge funds also recently made changes to their positions in ACHC. Principal Financial Group Inc. boosted its stake in Acadia Healthcare by 112.1% in the third quarter. Principal Financial Group Inc. now owns 442,943 shares of the company’s stock worth $10,967,000 after buying an additional 234,107 shares in the last quarter. Vanguard Group Inc. grew its stake in shares of Acadia Healthcare by 7.8% in the 3rd quarter. Vanguard Group Inc. now owns 9,417,045 shares of the company’s stock worth $233,166,000 after buying an additional 681,278 shares during the last quarter. First Citizens Bank & Trust Co. increased its position in shares of Acadia Healthcare by 164.1% during the third quarter. First Citizens Bank & Trust Co. now owns 59,123 shares of the company’s stock valued at $1,464,000 after acquiring an additional 36,733 shares in the last quarter. Public Sector Pension Investment Board purchased a new position in shares of Acadia Healthcare during the third quarter valued at approximately $8,919,000. Finally, Caxton Associates LLP lifted its stake in shares of Acadia Healthcare by 1,234.5% in the 2nd quarter. Caxton Associates LLP now owns 173,482 shares of the company’s stock worth $3,936,000 after purchasing an additional 160,482 shares during the period.

Acadia Healthcare Stock Performance

Shares of ACHC stock opened at $25.62 on Monday. Acadia Healthcare Company, Inc. has a one year low of $11.43 and a one year high of $31.43. The firm’s 50 day moving average price is $15.80 and its 200-day moving average price is $18.65. The firm has a market cap of $2.36 billion, a P/E ratio of -2.10, a P/E/G ratio of 8.66 and a beta of 0.73. The company has a debt-to-equity ratio of 1.27, a quick ratio of 1.55 and a current ratio of 1.55.

Acadia Healthcare (NASDAQ:ACHC) last announced its quarterly earnings data on Wednesday, February 25th. The company reported $0.07 EPS for the quarter, topping analysts’ consensus estimates of $0.03 by $0.04. Acadia Healthcare had a positive return on equity of 6.53% and a negative net margin of 33.29%.The business had revenue of $821.46 million during the quarter, compared to the consensus estimate of $800.10 million. During the same period in the previous year, the company posted $0.64 earnings per share. The business’s revenue for the quarter was up 6.1% on a year-over-year basis. Acadia Healthcare has set its FY 2026 guidance at 1.300-1.550 EPS and its Q1 2026 guidance at 0.250-0.300 EPS. As a group, equities research analysts predict that Acadia Healthcare Company, Inc. will post 3.38 EPS for the current year.

Analyst Upgrades and Downgrades

ACHC has been the subject of several research reports. TD Cowen increased their price objective on shares of Acadia Healthcare from $22.00 to $24.00 and gave the company a “buy” rating in a report on Thursday, February 26th. Jefferies Financial Group downgraded shares of Acadia Healthcare to a “hold” rating in a research report on Thursday, January 22nd. Cantor Fitzgerald set a $17.00 target price on Acadia Healthcare in a research note on Wednesday, December 3rd. Mizuho cut their price objective on shares of Acadia Healthcare from $22.00 to $17.00 and set a “neutral” rating on the stock in a research note on Thursday, December 18th. Finally, KeyCorp lowered their target price on Acadia Healthcare from $30.00 to $25.00 and set an “overweight” rating on the stock in a research note on Wednesday, December 3rd. Seven investment analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and two have assigned a Sell rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Hold” and an average target price of $21.15.

About Acadia Healthcare

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.